Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis
- PMID: 6858644
- DOI: 10.1111/j.1755-3768.1983.tb01394.x
Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis
Abstract
Eight patients with active toxoplasmic retinochoroiditis were treated with clindamycin and a triple sulphonamide combination for a period of up to 6 weeks. In addition systemic prednisone was administered when the optic nerve or the macula was involved (6 of the 8 cases). In all cases we observed clinical improvement within 2 weeks. Visual acuity improved in all cases. Side effects of the treatment were observed in 2 cases. The follow-up period ranged from 8 to 22 months.
MeSH terms
Substances
LinkOut - more resources
Medical